Literature DB >> 15607992

Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?

A Minguez-Castellanos1, F Escamilla-Sevilla, M J Katati, J M Martin-Linares, M Meersmans, A Ortega-Moreno, V Arjona.   

Abstract

BACKGROUND: Bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) is favoured over bilateral globus pallidus internus (Gpi) DBS for symptomatic treatment of advanced Parkinson's disease (PD) due to the possibility of reducing medication, despite lack of definitive comparative evidence.
OBJECTIVE: To analyse outcomes after one year of bilateral Gpi or STN DBS, with consideration of influence of selection bias on the pattern of postsurgical medication change.
METHODS: The first patients to undergo bilateral Gpi (n = 10) or STN (n = 10) DBS at our centre were studied. They were assessed presurgically and one year after surgery (CAPIT protocol).
RESULTS: Before surgery the Gpi DBS group had more dyskinesias and received lower doses of medication. At one year, mean reduction in UPDRS off medication score was 35% and 39% in the Gpi and STN groups, respectively (non-significant difference). Dyskinesias reduced in proportion to presurgical severity. The levodopa equivalent dose was significantly reduced only in the STN group (24%). This study high-lights the absence of significant differences between the groups in clinical scales and medication dose at one year. In the multivariate analysis of predictive factors for off-state motor improvement, the presurgical levodopa equivalent dose showed a direct relation in the STN and an inverse relation in the Gpi group.
CONCLUSION: Differences in the patterns of medication change after Gpi and STN DBS may be partly due to a patient selection bias. Both procedures may be equally useful for different subgroups of patients with advanced PD, Gpi DBS especially for patients with lower threshold for dyskinesia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607992      PMCID: PMC1739322          DOI: 10.1136/jnnp.2003.032623

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation.

Authors:  R Kumar; A M Lozano; E Sime; E Halket; A E Lang
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

2.  Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease.

Authors:  V Fraix; P Pollak; N Van Blercom; J Xie; P Krack; A Koudsie; A L Benabid
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

3.  Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD.

Authors:  J Volkmann; N Allert; J Voges; P H Weiss; H J Freund; V Sturm
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

4.  Mood changes with deep brain stimulation of STN and GPi: results of a pilot study.

Authors:  M S Okun; J Green; R Saben; R Gross; K D Foote; J L Vitek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

5.  Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.

Authors:  K J Burchiel; V C Anderson; J Favre; J P Hammerstad
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

6.  Core assessment program for intracerebral transplantations (CAPIT).

Authors:  J W Langston; H Widner; C G Goetz; D Brooks; S Fahn; T Freeman; R Watts
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

7.  Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus.

Authors:  M Krause; W Fogel; A Heck; W Hacke; M Bonsanto; C Trenkwalder; V Tronnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

8.  Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.

Authors:  P Krack; P Pollak; P Limousin; D Hoffmann; J Xie; A Benazzouz; A L Benabid
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

9.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  P Limousin; P Krack; P Pollak; A Benazzouz; C Ardouin; D Hoffmann; A L Benabid
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

10.  Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Authors:  Galit Kleiner-Fisman; David N Fisman; Elspeth Sime; Jean A Saint-Cyr; Andres M Lozano; Anthony E Lang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

View more
  12 in total

1.  Low FAB score as a predictor of future falling in patients with Parkinson's disease: a 2.5-year prospective study.

Authors:  Hiroshi Kataoka; Satoshi Ueno
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

2.  Network correlates of the cognitive response to levodopa in Parkinson disease.

Authors:  P J Mattis; C C Tang; Y Ma; V Dhawan; D Eidelberg
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

3.  Health-Related Quality of Life May Predict Disease Staging in 10 Years in Parkinson Disease With Hoehn-Yahr Stage III.

Authors:  Hiroshi Kataoka; Kazuma Sugie
Journal:  Neurol Clin Pract       Date:  2021-06

4.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

5.  STN DBS of Advanced Parkinson's Disease Experienced in a Specialized Monitoring Unit with a Prospective Protocol.

Authors:  Ji Yeoun Lee; Jung Ho Han; Han Joon Kim; Beom Seok Jeon; Dong Gyu Kim; Sun Ha Paek
Journal:  J Korean Neurosurg Soc       Date:  2008-07-20

6.  Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study.

Authors:  Steven A Gunzler; Caroline Koudelka; Nichole E Carlson; Misha Pavel; John G Nutt
Journal:  Arch Neurol       Date:  2008-02

7.  Association of Tef polymorphism with depression in Parkinson disease.

Authors:  Ping Hua; Weiguo Liu; Sheng-Han Kuo; Yanyan Zhao; Ling Chen; Ning Zhang; Chun Wang; Suwan Guo; Li Wang; Hong Xiao; Justin Y Kwan; Tianxia Wu
Journal:  Mov Disord       Date:  2012-11-08       Impact factor: 10.338

8.  Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson's disease.

Authors:  Hongyan Zhou; Cunzhou Shen; Jie Chen; Hao Qian; Yifan Zheng; Yanmei Liu; Wenbiao Xian; Zhong Pei; Ling Chen
Journal:  Transl Neurodegener       Date:  2014-10-22       Impact factor: 8.014

9.  Predictable Risk Factors for the Feeling of Presence in Patients with Parkinson's Disease.

Authors:  Hiroshi Kataoka; Satoshi Ueno
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

10.  Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications.

Authors:  Jan Vesper; Susanne Haak; Christoph Ostertag; Guido Nikkhah
Journal:  BMC Neurol       Date:  2007-03-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.